| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |